ROME (Reuters) – Italy’s top appeals court on Monday rejected a request by former prime minister Silvio Berlusconi to move two trials he faces out of Milan where, he has maintained, he cannot get a fair trial.
MUMBAI/NEW DELHI, Feb 13 (Reuters) – Slower government approval for testing new medicines is threatening India’s aspirations to be a fast-growing, low-cost hub for clinical trials, and has prompted some drugs firms to shift operations elsewhere, adding to their costs.
NEW YORK (Reuters Health) – Among people with advanced cancer, poorer patients are less likely to be referred for clinical trials of experimental drugs, a new study from the UK suggests.
NEW YORK (Reuters Health) – People participating in cancer drug trials aren’t always given the most straightforward explanation of possible risks and benefits from invasive procedures that may be involved, according to a new study.
May 7 (Reuters) – Insmed Inc can resume the development of its key drug Arikace after the U.S. health regulator lifted a second clinical hold on the drugmaker’s experimental treatment for lung disease, sending its shares up 47 percent.
ZURICH (Reuters) – A Novartis lung drug met its main goals in three late-stage studies in patients with chronic obstructive pulmonary disease (COPD), often known as smokers’ cough, the Swiss drugmaker said on Monday, giving its respiratory pipeline a boost.
(Reuters) – U.S. health regulators declined to approve Alimera Sciences Inc’s experimental drug to treat retinal swelling for the second time citing safety issues, and asked the biopharmaceutical…